Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Endpoint conclusion
Endpoint conclusion:
no study available (further information necessary)

Genetic toxicity in vivo

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

In silico assessments on the mutagenic potential using (Q)SAR methologies according to ICH M7 Guideline are accepted in the pharmaceutical context by regulators as valid tools for detecting DNA reactive substances (ICH=International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use; M7 Guideline is on "Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk").


Non-GLP Report Dec 4, 2019 (Wichard):


Aminopyrazole was predicted to be positive in DEREK based on the primary aromatic amine (Aromatic amine or amide #353). In agreement, the positive Leadscope prediction is based on the aromatic amine moiety. A VITIC query yielded positive Ames test data for Aminopyrazole (source: BHC report 40578, 2014.)

Justification for classification or non-classification

In addition to the bacterial reverse mutation test data (Ames test) an in silico prediction was performed. With regard to the prediction models used (Leadscope, DEREK, VITIC) the substance raised a strong structural alert for mutagenicity: positive prediction in DEREK, Leadscope and VITIC [Dec 2019].


 


Data lacking - without further data, a mutagenic potential cannot be excluded for the substance